Conditions: Bioequivalence Study in Healthy Subjects
Interventions: Drug: Rivastigmine TDS 9,5 mg/24 h; Drug: Exelon® 9.5 mg/24 h
Sponsors: Zodiac Produtos Farmaceuticos S.A.
Completed Conditions: Bioequivalence Study in Healthy Subjects
Interventions: Drug: Rivastigmine TDS 9,5 mg/24 h; Drug: Exelon® 9.5 mg/24 h
Sponsors: Zodiac Produtos Farmaceuticos S.A.
Completed
